High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer
Guoliang Wang(Kunming Medical University), Cheng Liu(Peking University), Qingsheng Nie(Central Hospital of Zibo), Chuanyou Xia(Shandong Provincial QianFoShan Hospital), Dawei Xu(Karolinska University Hospital), Luchao Li(Qilu Hospital of Shandong University), Zhenfeng Shi(Shandong First Medical University), Xiaofeng Li(Guangzhou Institute of Dermatology), Kun Wang(Chinese Academy of Sciences), Yi Huang(Ningbo University), Feilong Yang(Peking University), Yidong Fan(Guangxi University), Benkang Shi(Qingdao University), Yichang Hao(Peking University), Xiaojun Tian(University of Science and Technology of China), Li Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Lulin Ma(Peking University)
Cited by 32
Related Papers
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
|Cancer Cell|2016|1.2k
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players
|Oncogene|2019|465
Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning
|European Respiratory Journal|2019|441
The Role of Imaging in the Detection and Management of COVID-19: A Review
|IEEE Reviews in Biomedical Engineering|2020|420
A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy
|Clinical Cancer Research|2018|198